GDRX
GoodRx Holdings, Inc.
NasdaqGS Healthcare United States
3,36 $US
+2.44% today
+22.18% YTD · -26.64% 1Y
40
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
20
Hedge funds tracked
Latest available SEC 13F filings
54
/ 100
MIXED

Analysis GoodRx Holdings, Inc. (GDRX) — Kairos Score 54/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Key info

👔
CEO
Ms. Wendy Barnes
📍
HQ
2701 Olympic Boulevard, Santa Monica, CA, 90404, United States
👥
Employees
697
💰
Market cap
1 118 956 900,00 $US
📊
P/E
68.9
💸
Dividend yield
—

🕴️ Insider activity (90 days)

40 transactions — 0 buys and 14 sales reported by GoodRx Holdings, Inc. executives.

CT
Chan Thomas (TC)
Chief Accounting Officer · 2026-09-15
Other
CT
Chan Thomas (TC)
Chief Accounting Officer · 2026-09-15
Other
FJ
Fengler Justin
See Remarks · 2026-09-15
Other

🏦 Hedge Funds

20 institutional funds report a position on GDRX in their latest SEC quarterly filing.

VANGUARD GROUP INC
AMERIPRISE FINANCIAL INC
VANGUARD CAPITAL MANAGEMENT LLC
RENAISSANCE TECHNOLOGIES LLC
VANGUARD PORTFOLIO MANAGEMENT LLC

📰 Recent news

15 recent articles on GDRX.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as GoodRx Holdings, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of GDRX on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 40 insider transactions over 90 days
✅ All 20 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year